Form 4: Innoviva Director Sarah J. Schlesinger Reports Stock and Option Grant

Director Sarah J. Schlesinger reports the acquisition of Innoviva, Inc. stock and options following the company's 2025 annual meeting of stockholders.

Summary

• On May 19, 2025, Sarah J. Schlesinger, a director of Innoviva, Inc., reported the acquisition of 12,077 shares of common stock and options for 10,000 shares.
• The common stock was acquired at a price of $0.
• These transactions occurred following the conclusion of Innoviva's 2025 annual meeting of stockholders.
• The restricted stock units (RSUs) and options vest at the sooner of the next annual stockholder meeting or the one-year anniversary of the grant, contingent upon continuous service as an Outside Director.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and insider alignment with shareholder interests.

Positives

• The acquisition of stock and options by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs and options is contingent upon the director's continuous service, incentivizing continued involvement with the company.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in the company's securities.

Stakeholder Impact

• The acquisition of shares by a director can be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Innoviva, Director, Stock Options, Form 4, Beneficial Ownership, Sarah J. Schlesinger, INVA, Restricted Stock Units, RSUs